Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
University of British Columbia
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,202
total citations
- FWCI
- 44.95
- Percentile
- 100%
- References
- 112
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Matrix metalloproteinase
- Matrix metalloproteinase inhibitor
- Drug
- Drug development
- Cancer research
- Pharmacology
- Extracellular matrix
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.